Prasugrel in critically ill patients

While prasugrel is indicated for the treatment of myocardial infarction, its effects in the most severely affected patients requiring intensive care is unknown, so that we measured the antiplatelet effects and sparse pharmacokinetics of prasugrel in critically ill patients. Twenty-three patients adm...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Thromb Haemost
Prif Awduron: Schoergenhofer, Christian, Hobl, Eva-Luise, Staudinger, Thomas, Speidl, Walter S., Heinz, Gottfried, Siller-Matula, Jolanta, Zauner, Christian, Reiter, Birgit, Kubica, Jacek, Jilma, Bernd
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Schattauer GmbH 2017
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6292180/
https://ncbi.nlm.nih.gov/pubmed/28692105
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1160/TH17-03-0154
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg